ATP6V1H

ATP6V1H encodes the H subunit of the V1 domain of the vacuolar H⁺-ATPase (V-ATPase) and is essential for coupling ATP hydrolysis to proton translocation across endomembranes; it is not required for V-ATPase assembly but is indispensable for catalytic activation of the holoenzyme (PMID:8349704, PMID:10336497). Two alternatively spliced human isoforms (SFDα and SFDβ) are functionally interchangeable in reconstituting ATPase and proton-pumping activity, and the subunit bridges the V1 and V0 sectors (PMID:10336497). In bone, ATP6V1H haploinsufficiency causes osteoporosis by elevating osteoclast intracellular pH, reducing TGF-β1 activation and osteoblast induction, and de-repressing MMP9/MMP13, while it also regulates osteoblast differentiation through Akt/GSK3β signaling and physically interacts with integrin β1/β3/β5 subunits in osteoclasts (PMID:27924156, PMID:28158191, PMID:31272281, PMID:38203808). ATP6V1H additionally participates in HIV-1 Nef-mediated CD4 endocytosis through direct interaction with Nef, linking V-ATPase-dependent endosomal acidification to pathogen-driven membrane trafficking (PMID:9620685).

1. 1993 High

   The foundational question of whether V-ATPase subunit H is needed for complex assembly or for catalytic activity was resolved: Vma13p (yeast ATP6V1H ortholog) is dispensable for V-ATPase assembly and membrane targeting but is strictly required for ATPase enzymatic activity, establishing its role as a catalytic activator rather than a structural scaffold.

   Evidence Yeast VMA13 null mutant characterization with subcellular fractionation and enzyme activity assays

   PMID:8349704

   Open questions at the time

   • Mechanism by which subunit H activates hydrolysis/translocation coupling was not defined
   • Relevance of yeast findings to mammalian V-ATPase not yet tested
2. 1998 High

   The unexpected finding that HIV-1 Nef directly binds the human ATP6V1H homolog (NBP1) and requires it for CD4 downregulation revealed that subunit H operates at the interface of endosomal acidification and pathogen-hijacked membrane trafficking.

   Evidence Reciprocal co-immunoprecipitation, yeast two-hybrid, and antisense knockdown with CD4 surface expression readout

   PMID:9620685

   Open questions at the time

   • Structural basis of the Nef–subunit H interaction was not resolved
   • Whether Nef binding alters V-ATPase proton pumping activity was not tested
3. 1999 High

   Reconstitution of human subunit H isoforms into SFD-depleted V-ATPase established that two alternatively spliced variants (SFDα/SFDβ) are functionally interchangeable and that subunit H bridges the V1 and V0 sectors to activate both ATPase and proton-pumping activities.

   Evidence In vitro reconstitution of purified recombinant SFDα and SFDβ with SFD-depleted holoenzyme, ATPase and proton transport assays

   PMID:10336497

   Open questions at the time

   • Tissue- or context-specific roles of SFDα versus SFDβ were not examined
   • No structural data on how H subunit contacts V1-V0 interface
4. 2016 High

   The first in vivo mammalian loss-of-function study demonstrated that ATP6V1H haploinsufficiency causes osteoporosis by raising osteoclast intracellular pH, impairing TGF-β1 activation, and thereby reducing osteoblast recruitment — connecting V-ATPase proton pumping to bone remodeling.

   Evidence CRISPR/Cas9 Atp6v1h knockout mice with micro-CT, histomorphometry, intracellular pH measurements, and TGF-β1 pathway analysis

   PMID:27924156

   Open questions at the time

   • Whether TGF-β1 is the sole downstream mediator of the bone phenotype was not established
   • Human genetic validation for osteoporosis susceptibility was correlative (GWAS SNP) rather than causal
5. 2017 High

   Zebrafish atp6v1h knockout placed ATP6V1H genetically upstream of MMP9/MMP13 in bone formation, with pharmacological rescue by MMP inhibitors providing epistasis evidence for a V-ATPase–MMP axis distinct from the TGF-β1 pathway identified in mice.

   Evidence CRISPR/Cas9 zebrafish mutants with bone staining, expression analysis, and chemical rescue with MMP9/MMP13 inhibitors

   PMID:28158191

   Open questions at the time

   • Whether MMP upregulation reflects direct transcriptional control or is secondary to pH changes was unclear
   • Relationship between TGF-β1 and MMP9/MMP13 pathways downstream of ATP6V1H was not integrated
6. 2018 Medium

   Extension of the heterozygous mouse model to bone marrow stromal cells showed that ATP6V1H deficiency biases mesenchymal progenitor differentiation away from osteogenesis and toward adipogenesis, with downregulation of TGF-β receptor I and AP-2 complex components, broadening the bone phenotype to a progenitor cell-autonomous defect.

   Evidence Atp6v1h+/− mouse BMSCs with proliferation, cell cycle, and differentiation assays; qPCR for pathway markers

   PMID:29782852

   Open questions at the time

   • Pathway placement relied on gene expression changes without direct protein interaction or rescue data
   • Whether the adipogenic shift contributes to the in vivo osteoporosis phenotype was not shown
7. 2019 Medium

   Gain- and loss-of-function experiments in osteoblastic cells under diabetic-mimicking conditions placed ATP6V1H upstream of Akt/GSK3β signaling in promoting osteogenic differentiation, suggesting a second signaling axis in addition to TGF-β1.

   Evidence Overexpression and siRNA knockdown of ATP6V1H in MC3T3-E1 cells; western blot for phospho-Akt/GSK3β

   PMID:31272281

   Open questions at the time

   • Whether Akt/GSK3β modulation is direct or secondary to altered intracellular pH was not tested
   • Single cell-line study under non-physiological high-glucose/FFA conditions
8. 2022 Medium

   ATP6V1H deficiency was linked to glucose intolerance through augmented ER stress in pancreatic β-cells, extending the phenotypic spectrum beyond bone to metabolic homeostasis.

   Evidence Atp6v1h+/− mice on high-fat diet with glucose tolerance tests, insulin measurement, and transcriptome sequencing

   PMID:34990584

   Open questions at the time

   • Causal link between V-ATPase dysfunction and ER stress was correlative (transcriptomic)
   • Whether β-cell phenotype is cell-autonomous or secondary to systemic changes was not resolved
9. 2024 Medium

   Co-immunoprecipitation identified integrin β1, β3, β5, α2b, and α5 as direct physical partners of ATP6V1H in osteoclasts, connecting V-ATPase to a Fos-Jun-Src-integrin signaling axis and providing the first evidence of non-V-ATPase binding partners beyond HIV-1 Nef.

   Evidence Atp6v1h+/− mice in tail-suspension model; co-immunoprecipitation, transcriptomics, micro-CT

   PMID:38203808

   Open questions at the time

   • Integrin interactions detected by Co-IP only; reciprocal validation and domain mapping not reported
   • Functional consequence of integrin–ATP6V1H binding on V-ATPase activity or integrin signaling was not tested

• Key open questions remain: the structural basis for how subunit H bridges V1 and V0 sectors to activate proton pumping; whether the integrin, TGF-β1, MMP, and Akt/GSK3β downstream pathways converge or represent context-dependent outputs of luminal pH changes; and whether ATP6V1H loss-of-function mutations cause Mendelian skeletal or metabolic disease in humans.
• No high-resolution structure of human subunit H in the holoenzyme context
• No integration of the multiple downstream signaling pathways into a unified model
• No human Mendelian disease causally attributed to ATP6V1H mutations